Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Evaluation of Nigella sativa Seed Constituents for Their in vivo Toxicity in Mice

  • EI-Hadiyah, T.M. (Department of Pharmacology, College of Pharmacy, King Saud University) ;
  • Raza, M. (Department of Pharmacology, College of Pharmacy, King Saud University) ;
  • Mohammed, O.Y. (College of Pharmacy, Khartoum University) ;
  • Abdallah, A.A. (College of Pharmacy, Khartoum University)
  • Published : 2003.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was designed to investigate the effects of main constituents of Nigella sativa (NS) seed on the survival and CNS responses in experimental animals. The toxicological investigations were conducted for the determination of median lethal doses $(LD_{50})$ of NS seed constituents [i.e. aqueous extract (AE), fixed oil (FO), volatile oil (VO)] and main components of its VO [i.e. thymoquinone (TQ), ${\alpha}-pinene$ (AP) and p-cymene (PC)]. A part of this study includes evaluation NS constituents in the induction of minimal neurological deficit (MND) as a parameter for neurotoxicity using chimney test. In this study, the i.p. $LD_{50}$ values of AE, FO, VO, TQ (suspended In 0.5%CMC), TQ (dissolved in corn oil), AP and PC, were 3020, 3371, 1853, 616.6, 90.3, 1726 and 1523 mg/kg, respectively. All the NS constituents can be considered moderately toxic ($LD_{50}$ ranged from 616.6 to 3371 mg/kg), except the oily solution of TQ, which was very toxic ($LD_{50}$ was 90.3 mg/kg). It appeared that the toxicity of the whole VO is mainly due to its content of TQ and to some extent PC. All the NS constituents induced different degrees of MND at certain dose levels. The median neurotoxic (or sedating) doses $(TD_{50})$ of AE, FO, VO, TQ (suspended in CMC) and AP and PC, were 950, 1403, 306, 88.1, >173 and 368 mg/kg, respectively. TQ was the most potent component in inducing MND, whereas the FO and AE were the least. Neurotoxicity induced by the VO in the chimney test may refer basically to its contents of TQ and to some extent PC and AP.

Keywords

References

  1. Abdel-Fattah,A.M., Matsumoto, K. and Watanabe, H., Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur. J. Pharmacol. 14, 400,89-97 (2000)
  2. AbouBasha, L.I., Rashed, M.S. and Aboua-Enein,Y. TLC assay of thymoquinone in black seed oil (Nigella sativa) and identification of dithymoquinone and thymol. J. Liq. Chromatogr. 18, 105-115 (1995) https://doi.org/10.1080/10826079508009224
  3. Aboutabl, E.A., El-azzouny, A.A. and Hammerschmidt, F.J. Aroma volatile of Nigella sativa seeds. Prog Essent., Oil Res. Proc. Int. Symp. Essent. Oils $16^{th}$, 49-55. (1986)
  4. Akhtar, A.M., Ahmad, K.D., Gilani, S.N. and Nazir, A. Antiulcer effects of aqueous extracts of Nigella sativa and Pongamia pinnata in rats. Fitoterapia. 57, 195-199 (1996)
  5. Al Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res. 18(4), 163-8 (1991)
  6. Al Hader, A., Agel, M. and Hassan, Z. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int. J. Pharmacog. 13, 96-100 (1993)
  7. Al Jassir, M. S. Chemical composition and microflora of black cumin (Nigella sativa) seeds growing in Saudi Arabia. Food Chemistry, 45, 239-242 (1992) https://doi.org/10.1016/0308-8146(92)90153-S
  8. Babayan, V.K. Kootungal, D. and Halaby, G.A Proximate analysis, fatty acid and amino acid composition of Nigella sativa seeds. J. Food Sci. 43, 1314-1315 (1978) https://doi.org/10.1111/j.1365-2621.1978.tb15297.x
  9. Badary O., AI-Shabanah O., Nagi, M., AI-Bekairi, A. and Elmazar, M. Acute and subchronic toxicity of thymoquinone in mice. Drug Develop Res. 44, 56-61 (1998) https://doi.org/10.1002/(SICI)1098-2299(199806/07)44:2/3<56::AID-DDR2>3.0.CO;2-9
  10. Boissier, J.R., Tardy, J. and Diverres, J.C. A novel simple test for tranquilizing activity: The chimny test. Med. Exp. Basel, 3, 81-84 (1960) https://doi.org/10.1159/000134913
  11. Canonica, L., Jomoni, G., Scolastico and Bonati, A. The pharmacologically active principle in Nigella sativa. Gazz. Chem. Ital., 93, 1404-1407 (1963)
  12. Chakravarty, N. Inhibition of histamine release from mast cells by Nigellone. Ann. Allergy, 70, 237-242 (1993)
  13. EI-Alfy, TS, EI-Fatatry, HE, Toama, MA High performance liquid chromatographic analysis of the pharmacologically active quinines and related compounds in the oil of the black seeds (Nigella sativa L.). Pharmazie, 30, 109 (1975)
  14. EI Dakhakhny, M. Studies on the chemical constitution of Egyptian Nigella sative L. Seeds. Pharmazie, 30,109-111 (1963)
  15. EI Fatatry HM. Isolation and structure assignment of an antimicrobial principle from the volatile oil of Nigella sativa L. seeds. Pharmazie, 30(2), 109-11 (1975)
  16. El Kadi, A. and Kandil, O. Effect of Nigella sativa (the black seed). In proceedings of the $4^{th}$ International conference on Islamic medicine, Karachi, Pakistan (1986)
  17. EI Tahir, K.E.H. The medicinal effect of some vegetable oils and animal fats. A guide to the ideal healthy edible oil. Riyadh. (In Arabic) (1998)
  18. EI Tahir, K.E.H., Al Tahir, A Y. and Ageel, A.M. Pharmacological studies on Sesame and Nigella sativa fixed oils: effects on the sensitivities of the adrenoceptors, baroreceptors, platelets and uterus of the rat. Saudi Pharm. J., 7, 205-215 (1999)
  19. EI Tahir, K.E.H., Ashour, M.M. and Al Harbi, M.M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats. Elucidation of the mechanism of action. Gen. Pharmacol., 24, 1123-1131 (1993) https://doi.org/10.1016/0306-3623(93)90359-6
  20. Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal. 19(5), 757-62 (1999) https://doi.org/10.1016/S0731-7085(98)00300-8
  21. Hag, A., Al Tufail, M., Lobo, P.I., Khabar, K.S.A., Sheth, K.V. and AI-Sedairy, S.T. Polymorphnuclear leukocyte phagocytic activity. Immunopharmacology, 30, 147-155 (1995) https://doi.org/10.1016/0162-3109(95)00016-M
  22. Hashim, F.M. and EI-Kiey, M.A. Nigella sativa seeds of Egypt. J. Pharm. Sci. UAR, 3, 121-133 (1962)
  23. Houghton, P.J., Zaka, R., Hera, P.D. and Hoult, J.R.S. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica, 61, 33-36 (1995) https://doi.org/10.1055/s-2006-957994
  24. Khanna, T., Zaidi, F.A. and Dandiyn, P.C. CNS and analgesic studies on Nigella sativa. Fitoterapia, 64, 407-410 (1993)
  25. Klaassen, C. and Doull, J. Evaluation of safety: Toxicologic evaluation. In: Toxicology, the basic science of poisons. Editors: Klaassen, C., Doull, J. and Amdur, M.O., Macmillan publishing co. inc., pp. 11-27. (1980)
  26. Litchfield J., and Wilcoxon F.A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther., 257, 20-31. (1949)
  27. Mahfouz, M. and EI-Dakhakhny, M. The isolation of a crystalline active principle from Nigella sativa seeds. J. Pharm. Sci. UAR., 1, 9-19 (1960)
  28. Merk index $12^{th}$ edition, published by Merk research laboratories, USA. Merk and Co., lNC., Whitehouse station, N.J., USA (1996)
  29. Nagi, M., Alam, K., Badary, O., Al-Shabanah, O., Al-Sawaf, H., and Al-Bekairi, A. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem. Mol. BioI. Int., 47, 153-159 (1999)
  30. Nergiz, C. and Otles, S. Chemical composition of Nigella sativa seeds. Food Chemistry, XX, 259-261 (1993)
  31. Rathee, P.S., Mishra, S.H. and Kaushal, R. Antimicrobial activity of essential oil, fixed oil and unsaponifiable matter of Nigella sativa. Indian J. Pharm. Sci., 44, 8-10 (1982)
  32. Sayed, M. D. Traditional medicine in health care. J. Ethnopharmacol., 2, 19-22 (1980) https://doi.org/10.1016/0378-8741(80)90023-9